Manumap
  • Explore
  • Search
  1. Home
  2. Search
  3. Use Of Chemotherapy Plus A Monoclonal Antibody Against HER2 For Metastatic Breast Cancer That Overexpresses HER2

Use Of Chemotherapy Plus A Monoclonal Antibody Against HER2 For Metastatic Breast Cancer That Overexpresses HER2

·2001·DOI
Health Sciences and Innovation
Biomedical Engineering
Cancer Research and Treatment
Cancer Treatment Response Evaluation

Role in the Field

Neutralin Health Sciences and Innovation
Neutralin Biomedical Engineering
Neutralin Cancer Research and Treatment
Neutralin Cancer Treatment Response Evaluation

Abstract

Citations

10,162

Year

2001

PageRank

5.7 / 10

Relative influence (log-scaled)

Manumap

Explore the academic research landscape through interactive visualization and discovery tools.

Navigate

  • Explore Map
  • Search Papers
© 2026 Manumap. All rights reserved.